Cart
sales@molnova.com
Hepcidin-22 (human) trifluoroacetate salt
CAS No. 342790-22-1
Hepcidin-22 (human) trifluoroacetate salt( ——— )
Catalog No. M41736 CAS No. 342790-22-1
Hepcidin-22 (human) is an inactive degradation product of hepcidin-25 that is present in the urine.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHepcidin-22 (human) trifluoroacetate salt
-
NoteResearch use only, not for human use.
-
Brief DescriptionHepcidin-22 (human) is an inactive degradation product of hepcidin-25 that is present in the urine.
-
DescriptionHepcidin-22 (human) is an inactive degradation product of hepcidin-25 that is present in the urine.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number342790-22-1
-
Formula Weight2436.08
-
Molecular FormulaC99H151N29O25S9
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kroot JJ, et al. Hepcidin in human iron disorders: diagnostic implications. Clin Chem. 2011 Dec;57(12):1650-69.?
molnova catalog
related products
-
HPV16 E7 (86-93) (TF...
HPV16 E7 (86-93) TFA is a human leukocyte antigen (HLA)-A2.1 restricted HPV16 E7-derived peptide.
-
RH01386
RH01386 is a small molecule that can prevent ER stress-induced β cell dysfunction and death, and inhibits proapoptotic gene expression,has the potential for type 2 diabetes treatment. RH01386 restores ER stress-impaired glucose-stimulated insulin secretion responses.
-
SPA70
SPA70 is a selective pregnane X receptor (PXR) antagonist with an IC50 of 540 nM and Ki of 390 nM for human PCR and enhances the chemosensitivity of cancer cells.
